Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:18 pm Unchanged | 2023-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Armistice Capital, LLC | 976,000 2.730% | 0 (Unchanged) | Filing History |
| 2024-02-02 8:32 pm Purchase | 2023-09-29 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 2,121,753 6.100% | 2,121,753 (New Position) | Filing History |
| 2024-01-22 4:27 pm Purchase | 2023-06-26 | 13G | Aeglea BioTherapeutics, Inc. AGLE | Logos Global Management LP | 3,469,927 9.900% | 3,469,927 (New Position) | Filing History |
| 2023-07-14 4:30 pm Purchase | 2023-07-11 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings, L.P. | 59,961,729 9.990% | 59,961,729 (New Position) | Filing History |
| 2023-07-06 5:23 pm Purchase | 2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY | BIOTECHNOLOGY VALUE FUND L P | 3,470,225 9.990% | 3,470,225 (New Position) | Filing History |
| 2023-07-06 4:30 pm Purchase | 2023-06-26 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT L.P. | 3,470,689 9.990% | 3,470,689 (New Position) | Filing History |
| 2023-02-14 4:52 pm Sale | 2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,207,416 8.000% | -39,340 (-3.16%) | Filing History |
| 2023-02-14 1:41 pm Purchase | 2022-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Armistice Capital, LLC | 976,000 6.080% | 176,000 (+22.00%) | Filing History |
| 2022-02-14 9:37 pm Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Armistice Capital, LLC | 800,000 5.100% | 800,000 (New Position) | Filing History |
| 2022-02-14 08:35 am Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,246,756 8.000% | 1,246,756 (New Position) | Filing History |
| 2022-02-14 06:11 am Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Altium Capital Management LLC | 176,000 1.200% | 176,000 (New Position) | Filing History |
| 2022-01-20 4:23 pm Purchase | 2021-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Rosalind Advisors Inc. | 969,484 6.500% | 156,929 (+19.31%) | Filing History |
| 2021-09-23 4:54 pm Purchase | 2021-09-14 | 13G | Unicycive Therapeutics, Inc. UNCY | Rosalind Advisors Inc. | 812,555 5.600% | 812,555 (New Position) | Filing History |